A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer (opens ClinicalTrials.gov)
- Sponsor
- Astellas Pharma Global Development, Inc.
- Enrolment
- 398
- Started
- 2022-06-07
- Last update
- 2026-09-11
Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma
Interventions: ASP2138, Pembrolizumab, Oxaliplatin, Leucovorin…